These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1099634)

  • 1. [Isolation and characterization of a strain of E. coli K12 with a mutation affecting the transcription].
    García H; Lecocq JP
    Rev Latinoam Microbiol; 1975; 17(2):95-9. PubMed ID: 1099634
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proceedings: Effect of some "curing" agents on the resistance factors fi+ and fi-].
    Laub-Kupersztejn R; Thomas J; Pohl P
    Arch Int Physiol Biochim; 1975 May; 83(2):382-4. PubMed ID: 54098
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation of small plasmid from a deletion mutant of R100 in Escherichia coli K 12 strains.
    Alfaro G
    Rev Latinoam Microbiol; 1986; 28(2):139-44. PubMed ID: 3541098
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of F-prime, Col factor and R factor on the mutation phenotype in the Escherichia coli K12 strain].
    Kalaycioğlu A
    Mikrobiyol Bul; 1985 Jul; 19(3):127-32. PubMed ID: 3897801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New rifampin-resistant mutant of Escherichia coli.
    Marshall S; Gillespie D
    J Bacteriol; 1972 May; 110(2):782-3. PubMed ID: 4553848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulatory properties of RNA polymerase from rifampicin-resistant E. coli strain rpoB403].
    Kamzolova SG
    Biokhimiia; 1996 Aug; 61(8):1483-8. PubMed ID: 8962922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect on sublethal terizidon concentration on the mutation rate for streptomycin- and rifampicin resistance in E. coli].
    Urbanczik R
    Arzneimittelforschung; 1974 May; 24(5):723-5. PubMed ID: 4603888
    [No Abstract]   [Full Text] [Related]  

  • 8. Serotyping and transferability of drug resistance in clinical isolates of E. coli.
    Husain RA; Wadher BJ; Daginawala HF; Deshmukh SR; Nagoba BS
    Indian J Pathol Microbiol; 1995 Oct; 38(4):355-7. PubMed ID: 9726143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and physiological investigation of rifampicin-resistant RNA-polymerase mutants of Escherichia coli K-12. Communication I. Study of certain genotypic and phenotypic properties of rifampicin-resistant mutants.
    Alikhanyan SI; Tovmasyan KN; Severina IA
    Sov Genet; 1974 Sep; 8(10):1296-302. PubMed ID: 4612738
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell division and permeability of unbalanced envelope mutants of Escherichia coli K12.
    Normark S; Wolf-Watz H
    Ann Microbiol (Paris); 1974 Sep; 125 B(2):211-26. PubMed ID: 4617545
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isolation and characteristics of recombined-defective E. coli K-12 mutants].
    Rudneva SN; Pekhov AP
    Biull Eksp Biol Med; 1969 Jun; 68(7):100-2. PubMed ID: 4920783
    [No Abstract]   [Full Text] [Related]  

  • 12. Streptomycin-dependent rifampicin-resistant mutants of Escherichia coli K-12.
    Kalyaeva ES
    Sov Genet; 1974 Sep; 8(10):1283-9. PubMed ID: 4612736
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic and molecular characterization of pR351 plasmid from enteropathogenic Escherichia coli strain.
    Czarny A; Lagowska-Złotorzycka M; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):191-9. PubMed ID: 2695005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nucleotide substitutions in the rpoB gene leading to rifampicin resistance of E. coli RNA polymerase].
    Lisitsyn NA; Gur'ev SO; Sverdlov ED; Moiseeva EP; Nikiforov VG
    Bioorg Khim; 1984 Jan; 10(1):127-8. PubMed ID: 6385989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin curing of plasmids in Escherichia coli K12-rifampicin resistant host.
    Obaseiki-Ebor EE
    J Pharm Pharmacol; 1984 Jul; 36(7):467-70. PubMed ID: 6146694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible mechanism of fusidic acid resistance in E. coli.
    Werner RG; Daneck KH
    Arzneimittelforschung; 1981; 31(5):757-61. PubMed ID: 7023492
    [No Abstract]   [Full Text] [Related]  

  • 17. [The restriction of R factors in Salmonella typhimurium LT2 and E. coli].
    Palatini E; Lebek G
    Pathol Microbiol (Basel); 1974; 40(3):142-4. PubMed ID: 4602004
    [No Abstract]   [Full Text] [Related]  

  • 18. Physical characterization of N4-coded messenger RNA.
    Toni M; Casoli C; Conti G; Schito GC
    Ann Sclavo; 1975; 17(2):197-202. PubMed ID: 776100
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetical analysis of rifampicin resistant mutants of E. coli K 12.
    Mindlin SZ; Ilyina TS; Voeykova TA; Velkov VV
    Mol Gen Genet; 1972; 115(2):115-21. PubMed ID: 4554472
    [No Abstract]   [Full Text] [Related]  

  • 20. Dominance study with rifampicin-resistant mutants of E. coli K 12.
    Knüsel F; Schiess B
    Mol Gen Genet; 1970; 108(4):331-7. PubMed ID: 4924697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.